Poster Presentation: Alternative Methods of Anticoagulation in a Patient with A History of Heparin-Induced Thrombocytopenia

Availability

On-Demand

Expires on 02/20/2025

Cost

$0.00

Credit Offered

0.25 Class A Credit

Heparin is the standard anticoagulant in cardiovascular procedures due to its cost-effectiveness, availability, and reversibility. However, in patients with contraindications, such as a history of heparin-induced thrombocytopenia (HIT), alternative anticoagulants like argatroban may be necessary. This course provides an overview of safe and effective anticoagulation strategies for these special populations.

Participants will gain familiarity with the use of direct thrombin inhibitors, such as argatroban, as a viable alternative during procedures like carotid endarterectomy. The course will also discuss the nuanced decision-making involved in administering heparin to patients with a remote history of HIT, emphasizing that it is not always an absolute contraindication. Through this training, providers will be better equipped to manage anticoagulation in cardiovascular procedures when heparin cannot be used.

Learning Outcomes:

Demonstrate understanding of heparin-induced thrombocytopenia pathophysiology.
Identify the appropriate dosage for argatroban when administered for a cardiovascular procedure.
Identify appropriate patients who may be a candidate for heparin administration when known to have a history of heparin-induced thrombocytopenia undergoing a cardiovascular procedure.

This program has been prior approved by the American Association of Nurse Anesthesiology for 0.25 Class A CE credits; Code Number 1044802; Expiration Date 2/20/2025.

Sydni Flowers, BSN, RN

Accreditation Information:
The American Association of Nurse Anesthesiology is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

AANA is an approved provider by the California Board of Registered Nursing, CEP #10862.

Disclosure Statement:
Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Post-Test Attempt Notice:
A minimum passing score of 80% is required to pass this course. You have TWO opportunities to achieve a passing score. If you fail to achieve a passing score of 80%, you will not receive CE credit for this course.

Content Disclaimer:
The views, information, or opinions expressed within the videos and audio are solely those of the individuals involved and do not necessarily represent those of the American Association of Nurse Anesthesiology.

Course content has been prepared by the presenter/developer, and each viewer agrees that the presenter/developer is solely responsible for the content and the accuracy thereof. The viewer agrees that the American Association of Nurse Anesthesiology has no responsibility or liability for the accuracy or completeness of the content.

Refund Policy:
Continuing education activities are nonrefundable.